Health Condition 1: M179- Osteoarthritis of knee, unspecified
Conditions
Interventions
Intervention1: INDIVIDUALIZED HOMOEOPATHIC MEDICINE: GROUP A WILL RECIEVE INDIVIDUALIZED HOMOEOPATHIC MEDICINE.
Intervention2: INDIVIDUALIZED HOMOEOPATHIC MEDICINE: GROUP A WILL RECEIVE INDIVIDUALIZED
Sponsors
P P SAVANI HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: A. Age: Patients between the ages of 45 to 70 years. B. Diagnosis: Patients clinically diagnosed with osteoarthritis of the knee, confirmed through radiological findings based on the Kellgren-Lawrence grading scale (Grade I to III). C. Symptom Duration: Patients with a history of osteoarthritis symptoms (e.g., joint pain, stiffness) for at least 6 months. D. KOOS Score: Patients with moderate to severe knee function impairment, as reflected by the KOOS (Knee injury and Osteoarthritis Outcome Score). E. Consent: Patients willing to provide written informed consent and comply with the study procedures, including follow-ups. F. Ability to Participate: Patients physically and mentally capable of participating in assessments and reporting symptoms regularly.
Exclusion criteria
Exclusion criteria: A. Advanced Osteoarthritis: Patients with Kellgren-Lawrence Grade IV (end-stage OA) requiring surgical intervention such as total knee replacement. B. Comorbid Conditions: Patients with severe comorbidities, such as uncontrolled diabetes mellitus, cardiorespiratory diseases like congestive heart failure, uncontrolled hypertension, coronary artery disease, valvular heart disease, rheumatic heart disease, COPD, Allergic Asthma, and Chronic Asthma etc. , or any other chronic inflammatory diseases that could interfere with study results. The patient with controlled hypertension, non-progressive disease condition and only on anti-hypertensive drugs and not on any other steroidal or non-steroidal inflammatory drugs should be considered. C. Recent and Past Treatment History: Patients who are taking or who have taken following treatment in past 4 weeks; corticosteroids, NSAIDs, other disease-modifying osteoarthritis drugs (DMOADs), Physiotherapy, Ayurveda, Naturopathy and other forms of treatment. D. Surgical History: Patients with a history of knee surgery or joint replacement. E. Other Joint Diseases: Patients with concurrent rheumatologic diseases such as rheumatoid arthritis, gout, or ankylosing spondylitis. F. Pregnancy or Lactation: Female patients who are pregnant or breastfeeding. G. Non-compliance: Patients unwilling or unable to attend regular follow-ups or who do not adhere to treatment and assessment protocols.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| There is no significant difference in the effectiveness of individualized homoepathic medicine and pathological similimum (Rhus tox) in managing osteoarthritis of the knee as measured by the KOOS scale.Timepoint: 9 MONTH | — |
Secondary
| Measure | Time frame |
|---|---|
| Individualized homoeopathic medicine is more effective than pathological similimum (Rhus tox) in managing osteoarthritis of the knee as measured by the KOOS scale. Timepoint: 9 MONTH | — |
Countries
India
Contacts
Public ContactDR BHAVITA MALVI
P P Savani University
Outcome results
None listed